[1] Mavromati M, Jornayvaz FR. Hypothyroidism-associated dyslipidemia: potential molecular mechanisms leading to NAFLD[J]. Int J Mol Sci, 2021,22(23):12797. DOI: 10.3390/ijms222312797.
[2] Jonklaas J. Hypothyroidism, lipids, and lipidomics[J]. Endocrine, 2024,84(2):293-300. DOI: 10.1007/s12020-023-03420-9.
[3] Xu D, Zhong H. Correlation between hypothyroidism during pregnancy and glucose and lipid metabolism in pregnant women and its influence on pregnancy outcome and fetal growth and development[J]. Front Surg, 2022,9:863286. DOI: 10.3389/fsurg.2022.863286.
[4] Cai Y, Xu Y, Ban Y, et al. Plasma lipid profile and intestinal microflora in pregnancy women with hypothyroidism and their correlation with pregnancy outcomes[J]. Front Endocrinol (Lausanne), 2022,12:792536. DOI: 10.3389/fendo.2021.792536.
[5] Szczepanek-Parulska E, Sokolowski J, Dmowska D, et al. Lipid profile abnormalities associated with endocrine disorders[J]. Endokrynol Pol, 2022,73(5):863-871. DOI: 10.5603/EP.a2022.0059.
[6] Su X, Chen X, Peng H, et al. Novel insights into the pathological development of dyslipidemia in patients with hypothyroidism[J]. Bosn J Basic Med Sci, 2022,22(3):326-339. DOI: 10.17305/bjbms.2021.6606.
[7] Pearce EN. Management of hypothyroidism and hypothyroxinemia during pregnancy[J]. Endocr Pract, 2022,28(7):711-718. DOI: 10.1016/j.eprac.2022.05.004.
[8] Dhabhai N, Chowdhury R, Virmani A, et al. Burden, risk factors and outcomes associated with adequately treated hypothyroidism in a population-based cohort of pregnant women from North India[J]. PLoS One, 2023,18(9):e0282381. DOI: 10.1371/journal.pone.0282381.
[9] «妊娠和产后甲状腺疾病诊治指南»(第2版)编撰委员会,中华医学会内分泌学分会,中华医学会围产医学分会. 妊娠和产后甲状腺疾病诊治指南(第2版)[J]. 中华内分泌代谢杂志,2019,35(8):636-665. DOI:10.3760/cma.j.issn. 1000-6699.2019.08.003.
[10] Li J, Xu Y, Sun Z, et al. Differential lipids in pregnant women with subclinical hypothyroidism and their correlation to the pregnancy outcomes[J]. Sci Rep, 2021,11(1):19689. DOI: 10.1038/s41598-021-99252-6.
[11] Geno KA, Nerenz RD. Evaluating thyroid function in pregnant women[J]. Crit Rev Clin Lab Sci, 2022,59(7):460-479. DOI: 10.1080/10408363.2022.2050182.
[12] 丁永霞,金晶. 孕早期血清FT3/FT4对妊娠合并甲状腺功能减退患者母婴结局的影响[J]. 中南医学科学杂志,2024,52(1):87-90. DOI:10.15972/j.cnki.43-1509/r.2024.01.020.
[13] 李晶晶,许雅娟,蔡琰钧,等. 妊娠期亚临床甲状腺功能减退与脂质代谢的相关性研究[J]. 中国实用妇科与产科杂志,2022,38(2):211-215. DOI:10.19538/j.fk2022020119.
[14] 王雪冉,杨雨溪,刘瑞霞.亚临床甲状腺功能减退TSH水平对妊娠期脂代谢影响的研究进展[J].中国妇产科临床杂志,2022,23(06):662-664.DOI:10.13390/j.issn.1672-1861. 2022.06.035.
[15] 吴雪辉,李薇,吴欣瑜,等. 妊娠期甲状腺功能减退症患者血糖血脂水平与病情严重程度及妊娠结局的关系[J]. 中国计划生育学杂志,2023,31(1):182-186. DOI:10.3969/j.issn.1004-8189.2023.01.039.
[16] Lee SY, Pearce EN. Assessment and treatment of thyroid disorders in pregnancy and the postpartum period[J]. Nat Rev Endocrinol, 2022,18(3):158-171. DOI: 10.1038/s41574-021-00604-z.
[17] 罗丽娜,火睿,李爱玲,等. 妊娠特异性甲状腺激素参考值范围制定及妊娠期合并亚临床甲状腺功能减退预测模型的建立[J]. 实用妇产科杂志,2023,39(4):308-313.
[18] Islam A, Niazi SK. Frequency of subclinical hypothyroidism among pregnant women: a retrospective chart review[J]. Cureus, 2023,15(7):e41629. DOI: 10.7759/cureus.41629.
[19] 蔡琰钧,许雅娟,李晶晶,等. 妊娠合并甲状腺功能减退症患者血浆脂质组学分析及临床意义[J]. 实用妇产科杂志,2023,39(10):787-791.
[20] 孔玉玲,石国素,郑莉霞,等. 联合检测孕早期血脂指标、尿糖水平对妊娠期糖尿病及妊娠结局的预测价值研究[J]. 中国实验诊断学,2021,25(5):713-715. DOI:10.3969/j.issn.1007-4287.2021.05.021.
[21] Wu P, Wang Y, Ye Y, et al. Liver biomarkers, lipid metabolites, and risk of gestational diabetes mellitus in a prospective study among Chinese pregnant women[J]. BMC Med, 2023,21(1):150. DOI: 10.1186/s12916-023-02818-6.
[22] Cai E, Czuzoj-Shulman N, Malhamé I, et al. Maternal and neonatal outcomes in women with disorders of lipid metabolism[J]. J Perinat Med, 2021,49(9):1129-1134. DOI: 10.1515/jpm-2021-0028.
[23] Zhan Y, Wang J, He X, et al. Plasma metabolites, especially lipid metabolites, are altered in pregnant women with gestational diabetes mellitus[J]. Clin Chim Acta, 2021,517:139-148. DOI: 10.1016/j.cca.2021.02.023.
[24] Liu L, Zhang X, Qin K, et al. Characteristics of serum lipid metabolism among women complicated with hypertensive disorders in pregnancy: a retrospective cohort study in mainland China[J]. Obstet Gynecol Int, 2024,2024:9070748. DOI: 10.1155/2024/9070748.
[25] Jovandaric MZ, Babic S, Raus M, et al. The importance of metabolic and environmental factors in the occurrence of oxidative stress during pregnancy[J]. Int J Mol Sci, 2023,24(15):11964. DOI: 10.3390/ijms241511964.
|